Daslemia 100 Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Dasatinib (100mg)
Overview Daslemia 100 Tablet
Chronic myeloid leukemia (CML) is treated with Daslemia 100mg tablets. This medication is prescribed for patients whose CML hasn't responded to, or is intolerable with, other therapies. Daslemia 100mg can be administered with or without food, but consistent daily timing optimizes effectiveness. Dosage and frequency are determined by your physician based on your individual needs and may be adjusted. Strictly adhere to your doctor's instructions; incorrect usage or overdosage can have severe consequences. Therapeutic benefits might not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include nausea, vomiting, stomach pain, and skin rash. Increased heart rate and blood pressure fluctuations (high or low) are possible and necessitate immediate medical consultation. Regular blood pressure monitoring may be implemented. Avoid antacids for two hours before or after taking Daslemia 100mg. This medication can lower blood cell counts, raising infection risk; regular blood tests are essential. Inform your healthcare provider of all medications you're taking, as interactions are possible. Daslemia 100mg is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or blurred vision occur.
Uses of Daslemia 100 Tablet
Chronic myelogenous leukemia, a type of blood cancer
Major Benefits of Daslemia 100 Tablet:
Administer Daslemia 100 Tablet precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended for optimal results.
Common Side effects of Daslemia 100 Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Daslemia 100 Tablet:
Administer Daslemia 100 Tablet as directed by your physician, adhering precisely to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable, although consistent timing is recommended.
How Daslemia 100 Tablet works:
Oncasin 100mg tablets are a cancer treatment. Their mechanism involves inhibiting the activity of a faulty protein responsible for cancerous cell proliferation, thus hindering or slowing tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption with Daslemia 100 Tablet may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Daslemia 100 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Nursing mothers should avoid Daslemia 100 Tablet. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Daslemia 100 Tablets may induce adverse reactions that could impair driving ability. Exercise caution while operating a vehicle if you experience side effects like dizziness or blurred vision after taking Daslemia 100 Tablets.
KidneySAFE IF PRESCRIBED
Individuals with kidney disease can likely use Daslemia 100 Tablet safely. Available evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Daslemia 100 Tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Daslemia 100 Tablet :
Omit any missed Daslemia 100 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Daslemia 100 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently